Showing results (231-240 of 314) with videos related to
Sort By:
Pageof 32
International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acidS Cliffe, M L Taylor, M Rutland, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Correlation of the radiosensitization potency afforded by nitroacridine intercalators with their electron scavenging efficiency in DNAR F Anderson, W A Denny, P B Roberts, et al.American Journal of Otolaryngology|November 1, 1985
Paranasal sinus mucormycosis in an immunologically competent hostA K Pennisi, D M Parenti, A Stevens, et al.Journal of Medicinal Chemistry|March 3, 1999
Synthesis of 1-substituted 3-(chloromethyl)-6-aminoindoline (6-amino-seco-CI) DNA minor groove alkylating agents and structure-activity relationships for their cytotoxicityJ B Milbank, M Tercel, G J Atwell, et al.The Annals of Thoracic Surgery|November 11, 1992
Partial median sternotomy for repair of heart defects: a cosmetic approachW R Wilson, M N Ilbawi, S Y DeLeon, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalationW A Denny, P B Roberts, R F Anderson, et al.Antimicrobial Agents and Chemotherapy|September 1, 1982
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococciR Auckenthaler, W R Wilson, A J Wright, et al.Antimicrobial Agents and Chemotherapy|August 22, 2000
Trovafloxacin treatment of viridans group Streptococcus experimental endocarditisK E Piper, M S Rouse, K L Ronningen, et al.British Journal of Cancer|August 26, 1998
Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugsC J Lash, A E Li, M Rutland, et al.Antimicrobial Agents and Chemotherapy|August 1, 1997
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditisM S Rouse, J M Steckelberg, C M Brandt, et al.Pageof 32